Biochimica Et Biophysica Acta-molecular Basis Of Disease SCIE

期刊简介预计审稿时间： 一般,3-6周 约8.8周

BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease. This journal covers aspects of aging, cancer, metabolic-, neurological-, and immunological-based disease. Manuscripts focused on using animal models to elucidate biochemical and mechanistic insight in each of these conditions, are particularly encouraged. Manuscripts should emphasize the underlying mechanisms of disease pathways and provide novel contributions to the understanding and/or treatment of these disorders. Highly descriptive and method development submissions may be declined without full review. The submission of uninvited reviews to BBA - Molecular Basis of Disease is strongly discouraged, and any such uninvited review should be accompanied by a coverletter outlining the compelling reasons why the review should be considered.

BBA 疾病的分子基础 (BBA Molecular Basis of Disease) 致力于解决疾病过程和人类疾病模型的生物化学和分子遗传学问题。该期刊涵盖衰老、癌症、代谢、神经和免疫疾病等方面的内容。特别鼓励投稿专注于使用动物模型阐明每种疾病的生化和机制见解。稿件应强调疾病途径的潜在机制，并为理解和/或治疗这些疾病提供新颖的贡献。高度描述性和方法开发性投稿可能会在未经全面审查的情况下被拒绝。强烈反对向 BBA - 疾病的分子基础 (BBA - Molecular Basis of Disease) 提交未经邀请的评论，任何此类未经邀请的评论都应附上一封求职信，概述应考虑该评论的令人信服的理由。

《Biochimica Et Biophysica Acta-molecular Basis Of Disease》(Biochimica Et Biophysica Acta-molecular Basis Of Disease)编辑部通讯方式为ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。